National Institute of Neurological Disorders and Stroke; Notice of Meetings, 28054-28055 [2011-11779]
Download as PDF
28054
Federal Register / Vol. 76, No. 93 / Friday, May 13, 2011 / Notices
TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS—Continued
Study component
Number of respondents
Instrument
Average time per
response
(Minutes/Hour)
Frequency of response
Annual burden
hours
Saliva Protocol and Form (Attachment 15).
Heart Rate Monitor Log (Attachment 8).
Physical Activity Monitor Log (Accelerometer/Inclinometer)
(Attachment 12).
mstockstill on DSKH9S0YB1PROD with NOTICES
Total ............
742
3
10/60 (.167)
371
34
1
35/60 (.583)
20
742
2
35/60 (.583)
866
.........................................................
................................
................................
................................
15,060
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the
Attention: NIH Desk Officer, Office of
Management and Budget, at
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Heather
Bowles, Risk Factor Monitoring and
Methods Branch, Division of Cancer
Control and Population Sciences,
National Cancer Institute, 6130
Executive Blvd. MSC 7344, Bethesda,
MD 20892–7335 or call non-toll-free
number 301–496–7344 or e-mail your
request, including your address to:
bowleshr@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
VerDate Mar<15>2010
17:22 May 12, 2011
Jkt 223001
Dated: May 9, 2011.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2011–11824 Filed 5–12–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Advisory Neurological Disorders and
Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Clinical Trials Subcommittee.
Date: May 25, 2011.
Closed: 6:30 p.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Open: 8 p.m. to 8:30 p.m.
Agenda: To discuss clinical trials policy.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Petra Kaufmann, MD,
Director, Office of Clinical Research—NINDS,
National Institutes of Health, Neuroscience
Center—Room 2216, 6001 Executive Blvd.,
Bethesda, MD 20892, 301–496–
9135,Kaufmanp2@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to timing
limitations imposed by the review funding
cycle.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Basic and Preclinical Programs
Subcommittee.
Date: May 26, 2011.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
Bethesda, MD 20892.
Closed: 9 a.m. to 9:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
Bethesda, MD 20892.
Contact Person: Walter Joseph Koroshetz,
MD, Deputy Director, NINDS, Building 31,
Room 8A52, 31 Center Drive, MSC 2540,
301–496–3167, Koroshetzw@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to timing
limitations imposed by the review funding
cycle.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council
Training, Career Development, and Special
Programs Subcommittee.
Date: May 26, 2011.
Open: 9:30 a.m. to 10:30 a.m.
Agenda: To discuss the training plan of the
institute.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
Bethesda, MD 20892.
Contact Person: Stephen J. Korn, PhD,
Training and Special Programs Officer,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
E:\FR\FM\13MYN1.SGM
13MYN1
Federal Register / Vol. 76, No. 93 / Friday, May 13, 2011 / Notices
6001 Executive Blvd., Suite 2154, MSC 9527,
Bethesda, MD 20892–9527, 301–496–4188.
This notice is being published less than 15
days prior to the meeting due to timing
limitations imposed by the review funding
cycle.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–11779 Filed 5–12–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSKH9S0YB1PROD with NOTICES
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health (NIH).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Date: June 9–10, 2011.
Closed: June 9, 2011, 9:30 a.m. to 10:30
a.m.
Agenda: Review of the Pioneer and
Innovator Awards.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor, Conference
Room 6, 31 Center Drive, Bethesda, MD
20892.
Open: June 9, 2011, 10:30 a.m. to 5 p.m.
June 10, 2011, 8 a.m. to 4 p.m.
Agenda: NIH Director’s Report, NIH
updates, and other committee business.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor, Conference
Room 6, 31 Center Drive, Bethesda, MD
20852.
Contact Person: Gretchen Wood, Senior
Assistant to the Deputy Director, Office of the
Director, National Institutes of Health, One
Center Drive, Building 1, Room 114,
Bethesda, MD 20892, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nih.gov/about/director/acd.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: May 5, 2011.
Jennifer S. Spaeth.
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–11791 Filed 5–12–11; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: Advisory Committee
to the Director, NIH.
VerDate Mar<15>2010
17:22 May 12, 2011
Jkt 223001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
28055
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
Date: June 3, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Ruixia Zhou, PhD,
Scientific Review Officer, 6707 Democracy
Boulevard, Democracy Two Building, Suite
957, Bethesda, MD 20892, 301–496–4773,
zhour@mail.nih.gov.
Dated: May 9, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–11798 Filed 5–12–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\13MYN1.SGM
13MYN1
Agencies
[Federal Register Volume 76, Number 93 (Friday, May 13, 2011)]
[Notices]
[Pages 28054-28055]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-11779]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the
National Advisory Neurological Disorders and Stroke Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Clinical Trials Subcommittee.
Date: May 25, 2011.
Closed: 6:30 p.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Open: 8 p.m. to 8:30 p.m.
Agenda: To discuss clinical trials policy.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Petra Kaufmann, MD, Director, Office of Clinical
Research--NINDS, National Institutes of Health, Neuroscience
Center--Room 2216, 6001 Executive Blvd., Bethesda, MD 20892, 301-
496-9135,Kaufmanp2@ninds.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to timing limitations imposed by the review funding
cycle.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council, Basic and Preclinical Programs Subcommittee.
Date: May 26, 2011.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss basic and preclinical programs policy.
Place: National Institutes of Health, Building 31, C Wing,
Conference Room 10, Bethesda, MD 20892.
Closed: 9 a.m. to 9:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Walter Joseph Koroshetz, MD, Deputy Director,
NINDS, Building 31, Room 8A52, 31 Center Drive, MSC 2540, 301-496-
3167, Koroshetzw@ninds.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to timing limitations imposed by the review funding
cycle.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council Training, Career Development, and Special Programs
Subcommittee.
Date: May 26, 2011.
Open: 9:30 a.m. to 10:30 a.m.
Agenda: To discuss the training plan of the institute.
Place: National Institutes of Health, Building 31, C Wing,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Stephen J. Korn, PhD, Training and Special
Programs Officer, National Institute of Neurological Disorders and
Stroke, National Institutes of Health,
[[Page 28055]]
6001 Executive Blvd., Suite 2154, MSC 9527, Bethesda, MD 20892-9527,
301-496-4188.
This notice is being published less than 15 days prior to the
meeting due to timing limitations imposed by the review funding
cycle.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.ninds.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: May 6, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-11779 Filed 5-12-11; 8:45 am]
BILLING CODE 4140-01-P